Cellular and Molecular Neurobiology

, Volume 31, Issue 4, pp 597–604

Latanoprost Promotes Neurite Outgrowth in Differentiated RGC-5 Cells via the PI3K-Akt-mTOR Signaling Pathway

Original Research


Latanoprost, a synthetic derivative of the natural prostaglandin F2a (PGF2a), is a powerful antiglaucoma agent with ocular hypotensive and neuroprotective effects. However, the neuroregenerative effect and signaling pathway of latanoprost in retinal ganglion cells (RGCs) are still unknown. The purpose of this study is to investigate the regenerative effect of latanoprost in differentiated RGC-5 cells and its underlying mechanisms. Cell viability was determined by Cell Counting Kit-8 (CCK-8) assay and neurite length was examined by ArrayScan HCS Reader and Neurite outgrowth BioApplication. Expressions of Akt phosphorylation (p-Akt) and mammalian target of rapamycin phosphorylation (p-mTOR) were investigated by Western blot analysis. The results indicated that 0.1 μM latanoprost (at a clinically therapeutic concentration) significantly increased cell viability as compared with control. Meanwhile, 0.1 μM latanoprost resulted in the obvious promotion of neurite outgrowth similar to ciliary neurotrophic factor (CNTF) and simultaneously increased the levels of p-Akt and p-mTOR expression. The effects of latanoprost were blocked by the Prostaglandin F receptor (FP receptor) inhibitor AL8810, the phosphoinositide 3-kinase (PI3K) inhibitor LY294002 and the mTOR inhibitor rapamycin. This study presents novel in vitro evidence that latanoprost could promote neurite outgrowth through an FP receptor-mediated modulation of the PI3K-Akt-mTOR signaling pathway. This finding may provide insight into a better understanding of a new mechanism of latanoprost for glaucoma therapy and into the physiological-modulating activities of prostaglandins.


Latanoprost Neurite outgrowth Phosphatidylinositol 3-kinase Mammalian target of rapamycin Retinal ganglion cells 


  1. Ahmed Z, Berry M, Logan A (2009) ROCK inhibition promotes adult retinal ganglion cell neurite outgrowth only in the presence of growth promoting factors. Mol Cell Neurosci 42:128–133PubMedCrossRefGoogle Scholar
  2. Alm A, Stjernschantz J (1995) Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol, Scandinavian latanoprost study group. Ophthalmology 102:1743–1752PubMedGoogle Scholar
  3. Chen C, Bazan NG (2005) Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Prostaglandins Other Lipid Mediat 77:65–76PubMedCrossRefGoogle Scholar
  4. Dahlmann-Noor AH, Vijay S, Limb GA, Khaw PT (2010) Strategies for optic nerve rescue and regeneration in glaucoma and other optic neuropathies. Drug Discov Today 15(7–8):287–299PubMedCrossRefGoogle Scholar
  5. Drago F, Valzelli S, Emmi I, Marino A, Scalia CC, Marino V (2001) Latanoprost exerts neuroprotective activity in vitro and in vivo. Exp Eye Res 72:479–486PubMedCrossRefGoogle Scholar
  6. Grider MH, Park D, Spencer DM, Shine HD (2009) Lipid raft-targeted Akt promotes axonal branching and growth cone expansion via mTOR and Rac1, respectively. J Neurosci Res 87:3033–3042PubMedCrossRefGoogle Scholar
  7. Hansen MR, Roehm PC, Xu N, Green SH (2007) Overexpression of Bcl-2 or Bcl-xL prevents spiral ganglion neuron death and inhibits neurite growth. Dev Neurobiol 67(3):316–325PubMedCrossRefGoogle Scholar
  8. Harrill JA, Freudenrich TM, Machacek DW, Stice SL, Mundy WR (2010) Quantitative assessment of neurite outgrowth in human embryonic stem cell-derived hN2 cells using automated high-content image analysis. Neurotoxicology 31(3):277–290PubMedCrossRefGoogle Scholar
  9. Hernández M, Urcola JH, Vecino E (2008) Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments. Exp Eye Res 86(5):798–806PubMedCrossRefGoogle Scholar
  10. Jover-Mengual T, Miyawaki T, Latuszek A, Alborch E, Zukin RS, Etgen AM (2010) Acute estradiol protects CA1 neurons from ischemia-induced apoptotic cell death via the PI3K/Akt pathway. Brain Res 1321:1–12PubMedCrossRefGoogle Scholar
  11. Ju WK, Liu Q, Kim KY, Crowston JG (2007) Elevated hydrostatic pressure triggers mitochondrial fission and decreases cellular ATP in differentiated RGC-5 cells. Invest Ophthalmol Vis Sci 48:2145–2151PubMedCrossRefGoogle Scholar
  12. Ju WK, Kim KY, Lindsey JD, Angert M, Patel A, Scott RT, Liu Q, Crowston JG, Ellisman MH, Perkins GA, Weinreb RN (2009) Elevated hydrostatic pressure triggers release of OPA1 and cytochrome C, and induces apoptotic cell death in differentiated RGC-5 cells. Mol Vis 15:120–134PubMedGoogle Scholar
  13. Kanamori A, Naka M, Fukuda M, Nakamura M, Negi A (2009) Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo. Exp Eye Res 88:535–541PubMedCrossRefGoogle Scholar
  14. Kretz A, Happold CJ, Marticke JK, Isenmann S (2005) Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol Cell Neurosci 29(4):569–579PubMedCrossRefGoogle Scholar
  15. Krishnamoorthy RR, Agarwal P, Prasanna G, Vopat K, Lambert W, Sheedlo HJ, Pang IH, Shade D, Wordinger RJ, Yorio T, Clark AF, Agarwal N (2001) Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res 86:1–12PubMedCrossRefGoogle Scholar
  16. Kudo H, Nakazawa T, Shimura M, Takahashi H, Fuse N, Kashiwagi K, Tamai M (2006) Neuroprotective effect of latanoprost on rat retinal ganglion cells. Graefes Arch Clin Exp Ophthalmol 244:1003–1009PubMedCrossRefGoogle Scholar
  17. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, Li Y, Baker SJ, Parada LF (2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50:377–388PubMedCrossRefGoogle Scholar
  18. Li L, Xu B, Zhu Y, Chen L, Sokabe M, Chen L (2010) DHEA prevents Abeta(25–35)-impaired survival of newborn neurons in the dentate gyrus through a modulation of PI(3)K-Akt-mTOR signaling. Neuropharmacology 59:323–333PubMedCrossRefGoogle Scholar
  19. Lindsley CW (2010) The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update. Curr Top Med Chem 10:458–477PubMedCrossRefGoogle Scholar
  20. Lingor P, Tönges L, Pieper N, Bermel C, Barski E, Planchamp V, Bähr M (2008) ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate proliferation and regeneration in retinal ganglion cells. Brain 131:250–263PubMedGoogle Scholar
  21. Liu D, McIlvain HB, Fennell M, Dunlop J, Wood A, Zaleska MM, Graziani EI, Pong K (2007) Screening of immunophilin ligands by quantitative analysis of neurofilament expression and neurite outgrowth in cultured neurons and cells. J Neurosci Methods 163(2):310–320PubMedCrossRefGoogle Scholar
  22. McMahon LP, Yue W, Santen RJ, Lawrence JC Jr (2005) Farnesyl thiosalicylic acid inhibits mammalian target of rapamycin (mTOR) activity both in cells and in vitro by promoting dissociation of the mTOR-raptor complex. Mol Endocrinol 19:175–183PubMedCrossRefGoogle Scholar
  23. Mizuno K, Koide T, Saito N, Fujii M, Nagahara M, Tomidokoro A, Tamaki Y, Araie M (2002) Topical nipradilol: effects on optic nerve head circulation in humans and periocular distribution in monkeys. Invest Ophthalmol Vis Sci 43:3243–3250PubMedGoogle Scholar
  24. Morquette JB, Di Polo A (2008) Dendritic and synaptic protection: is it enough to save the retinal ganglion cell body and axon? J Neuroophthalmol 28:144–154PubMedGoogle Scholar
  25. Müller A, Hauk TG, Leibinger M, Marienfeld R, Fischer D (2009) Exogenous CNTF stimulates axon regeneration of retinal ganglion cells partially via endogenous CNTF. Mol Cell Neurosci 41:233–246PubMedCrossRefGoogle Scholar
  26. Nakanishi Y, Nakamura M, Mukuno H, Kanamori A, Seigel GM, Negi A (2006) Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mitogen-activated protein kinase. Exp Eye Res 83(5):1108–1117PubMedCrossRefGoogle Scholar
  27. Narayanan SP, Flores AI, Wang F, Macklin WB (2009) Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J Neurosci 29:6860–6870PubMedCrossRefGoogle Scholar
  28. Osborne NN, Ji D, Abdul Majid AS, Fawcett RJ, Sparatore A, Del Soldato P (2010) ACS67, a hydrogen sulfide-releasing derivative of latanoprost acid, attenuates retinal ischemia and oxidative stress to RGC-5 cells in culture. Invest Ophthalmol Vis Sci 51(1):284–294PubMedCrossRefGoogle Scholar
  29. Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, Xu B, Connolly L, Kramvis I, Sahin M, He Z (2008) Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322:869–872CrossRefGoogle Scholar
  30. Park KK, Liu K, Hu Y, Kanter JL, He Z (2010) PTEN/mTOR and axon regeneration. Exp Neurol 223:45–50PubMedCrossRefGoogle Scholar
  31. Radio NM, Breier JM, Shafer TJ, Mundy WR (2008) Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening. Toxicol Sci 105(1):106–118PubMedCrossRefGoogle Scholar
  32. Read DE, Reed Herbert K, Gorman AM (2008) Heat shock enhances NGF-induced neurite elongation which is not mediated by Hsp25 in PC12 cells. Brain Res 1221:14–23PubMedCrossRefGoogle Scholar
  33. Rock Nathan, Shravan K, Chintala (2008) Mechanisms regulating plasminogen activators in transformed retinal ganglion cells. Exp Eye Res 86:492–499PubMedCrossRefGoogle Scholar
  34. Van Bergen NJ, Wood JP, Chidlow G, Trounce IA, Casson RJ, Ju WK, Weinreb RN, Crowston JG (2009) Recharacterization of the RGC-5 retinal ganglion cell line. Invest Ophthalmol Vis Sci 50:4267–4272PubMedCrossRefGoogle Scholar
  35. Vidal L, Díaz F, Villena A, Moreno M, Campos JG, de Pérez Vargas I (2010) Reaction of Müller cells in an experimental rat model of increased intraocular pressure following timolol, latanoprost and brimonidine. Brain Res Bull 82:18–24PubMedCrossRefGoogle Scholar
  36. Villena A, Diaz F, Vidal L, Moreno M, Garcia-Campos J, De Perez Vargas I (2009) Study of the effects of ocular hypotensive drugs on number of neurons in the retinal ganglion layer in a rat experimental glaucoma. Eur J Ophthalmol 19:963–970PubMedGoogle Scholar
  37. Wood JP, Chidlow G, Tran T, Crowston JG, Casson RJ (2010) A comparison of differentiation protocols for RGC-5 cells. Invest Ophthalmol Vis Sci 51(7):3774–3783PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Jun Zheng
    • 1
  • Xuemei Feng
    • 1
  • Lina Hou
    • 1
  • Yongyao Cui
    • 1
  • Liang Zhu
    • 1
  • Jian Ma
    • 1
  • Zheng Xia
    • 1
  • Wei Zhou
    • 1
  • Hongzhuan Chen
    • 1
  1. 1.Department of Pharmacology, Institute of Medical SciencesShanghai Jiao Tong University School of MedicineShanghaiChina

Personalised recommendations